A detailed history of Mutual Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mutual Advisors, LLC holds 11,582 shares of AZN stock, worth $768,581. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,582
Previous 12,524 7.52%
Holding current value
$768,581
Previous $976,000 7.58%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$76.67 - $87.62 $72,223 - $82,538
-942 Reduced 7.52%
11,582 $902,000
Q2 2024

Jul 30, 2024

BUY
$66.81 - $80.83 $78,635 - $95,136
1,177 Added 10.37%
12,524 $976,000
Q1 2024

May 02, 2024

BUY
$61.03 - $69.57 $100,150 - $114,164
1,641 Added 16.91%
11,347 $768,000
Q4 2023

Jan 12, 2024

SELL
$61.89 - $69.28 $13,430 - $15,033
-217 Reduced 2.19%
9,706 $653,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $92,735 - $102,531
1,430 Added 16.84%
9,923 $671,000
Q2 2023

Jul 31, 2023

BUY
$69.91 - $75.81 $19,574 - $21,226
280 Added 3.41%
8,493 $607,000
Q1 2023

Apr 11, 2023

SELL
$63.15 - $71.6 $67,381 - $76,397
-1,067 Reduced 11.5%
8,213 $570,000
Q4 2022

Jan 12, 2023

SELL
$54.21 - $70.44 $188,000 - $244,285
-3,468 Reduced 27.2%
9,280 $0
Q3 2022

Nov 03, 2022

BUY
$53.02 - $135.75 $185,304 - $474,446
3,495 Added 37.77%
12,748 $699,000
Q2 2022

Aug 15, 2022

SELL
$59.26 - $71.14 $15,940 - $19,136
-269 Reduced 2.83%
9,253 $611,000
Q1 2022

May 09, 2022

SELL
$55.72 - $67.12 $31,593 - $38,057
-567 Reduced 5.62%
9,522 $632,000
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $216 - $255
4 Added 0.04%
10,089 $588,000
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $102,285 - $111,914
1,841 Added 22.33%
10,085 $606,000
Q2 2021

Aug 12, 2021

BUY
$48.42 - $60.18 $9,393 - $11,674
194 Added 2.41%
8,244 $494,000
Q1 2021

May 13, 2021

SELL
$47.16 - $54.44 $60,034 - $69,302
-1,273 Reduced 13.65%
8,050 $400,000
Q4 2020

Feb 11, 2021

BUY
$48.52 - $58.02 $2,862 - $3,423
59 Added 0.64%
9,323 $466,000
Q3 2020

Nov 13, 2020

SELL
$53.07 - $61.1 $3,502 - $4,032
-66 Reduced 0.71%
9,264 $508,000
Q2 2020

Aug 05, 2020

BUY
$43.1 - $55.31 $16,291 - $20,907
378 Added 4.22%
9,330 $493,000
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $12,055 - $16,374
-319 Reduced 3.44%
8,952 $400,000
Q4 2019

Feb 11, 2020

BUY
$42.46 - $50.46 $393,646 - $467,814
9,271 New
9,271 $462,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.